Controversies in Nephrology: An Academic Debate

Maggiano’s Little Italy, 516 N Clark St.
Chicago, Illinois 60654

Tuesday, June 2, 2015

Congratulations to this year's Controversies in Nephrology debate winners: Rush University & University of Illinois at Chicago. A huge congrats also goes out to this years first annual audience favorite award recipient as well: Rush University.

To see photos from this year's event, click here.

Thank you everyone for coming out!

Controversies in Nephrology: An Academic Debate is an interactive, participatory debate among nephrology fellows representing Chicago’s medical academic centers.

Debate topics are chosen based on their relevance and association with the nephrology/transplant fields. Entry includes dinner, along with an evening of networking and education for nephrologists, transplant surgeons and allied health professionals.

2015 Debate Teams & Topics:

  • Loyola University (PRO) vs. Rush University (CON): The use of warfarin-based anticoagulation in ESRD patients with atrial fibrillation should be continued
  • University of Illinois at Chicago (PRO) vs. Northwestern University (CON): V2 receptor antagonists are superior to conventional therapies for the management of euvolemic hyponatremia and should become standard of care

To see photos from last year's event, click here.

For more information, please contact Mara Lidacis at mlidacis@nkfi.org or (312) 321-1500.

Event Details

Registration Fees:
Event + Professional Advisory Board Membership: $150
Event Only: $65
Fellows, residents & medical students: Free (registration still required)

Event Schedule:
5:30 – 6:00 PM – Professional Advisory Board Annual Meeting, Barbera Room (all current Professional Advisory Board members welcome)
5:45 – 6:30 PM – Registration Open, Networking & Cocktail Reception
6:30 PM  – Debates Begin

Event Location:
Maggiano's Little Italy
516 N. Clark St.
Chicago, IL 60654

2015 Debate Teams & Topics:
Loyola University (PRO) vs. Rush University (CON): The use of warfarin-based anticoagulation in ESRD patients with atrial fibrillation should be continued

University of Illinois at Chicago (PRO) vs. Northwestern University (CON): V2 receptor antagonists are superior to conventional therapies for the management of euvolemic hyponatremia and should become standard of care

Sponsors

Alexion Pharmaceuticals

Fresenius Medical Care

Genzyme

Keryx Biopharmaceuticals

NxStage Medical

This program is made possible each year through input and support from many generous sponsors and exhibitors. For more information on available opportunities, please contact Mara Lidacis at mlidacis@nkfi.org or (312) 321-1500.


Tags: professional